FDA to Investigate Diabetes Drug Saxagliptin for Possible Heart Failure Risk

U.S. News & World Report
February 11, 2014
FDA to Investigate Diabetes Drug Saxagliptin for Possible Heart Failure Risk

Featuring: Dr. Tara Narula, Associate Director, Cardiac Care Unit, Lenox Hill Hospital

Read this Story

Topics: News

Focus onHealth TV

Watch Focus onHealth, Northwell Health's TV show. It's the healthy way to stay informed!